Browsing: Weight Loss

Data from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), specifically its Yellow Card Biobank, suggests that GLP-1s are not only linked to deaths but thousands of instances of other, less serious symptoms, such as gastrointestinal issues and nervous system disorders

Eli Lilly (NYSE:LLY) just added another weapon to its obesity arsenal. The pharmaceutical giant received British authorization for Foundayo on Monday, making the U.K. the first European country to clear the once-daily orforglipron tablet for weight management and type 2 diabetes. Lilly shares rose approximately 2.1% in regular trading. The appeal is easy to understand:…

Eli Lilly’s new weight-loss pill orforglipron – brand named Foundayo – has been authorised today (10 August) by the Medicines and Healthcare products Regulatory Agency (MHRA)